Curcumin, a natural, biologically active compound extracted from rhizomes of Curcuma species, has been shown to possess potent anti-inflammatory, anti-tumor, and anti-oxidative properties. The mechanism by which curcumin initiates apoptosis remains poorly understood. In the present report we investigated the effect of curcumin 
Introduction
Curcumin [1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione] is the major constituent of turmeric power extracted from the rhizomes of the plant Curcuma longa found in south and southeast tropical Asia. It has been used for centuries in indigenous medicine for the treatment of a variety of inflammatory conditions and other disease (1). Several studies in recent years have shown that curcumin is a potent inhibitor of tumor initiation in vivo (2, 3) and possesses anti-proliferative activities against tumor cells in vitro (4). Curcumin is also a potent chemopreventive agent inhibiting tumor promotion against skin, oral, intestinal, and colon carcinogenesis (5, 6).
The cancer chemopreventive activity of curcumin in human has yet to be confirmed, however. Recent evidence indicates that curcumin suppresses a number of key elements in cellular signal transduction pathways. Prominent among the signaling events inhibited by curcumin are phosphorylations catalyzed by protein kinases (7), c-Jun/Ap-1 activation (8), prostaglandin biosynthesis (9). All of these inhibitory actions of curcumin require concentrations of the agent in the 10-100 µM range. Recently, it has been reported that curcumin treatment resulted in the production of reactive oxygen species (ROS) (10, 11). ROS is involved in the initiation and progression of a variety of human diseases (12), including renal ischemia/reperfusion injury and in toxicities associated with chemical exposure. The kidney or kidney-derived cells have an increased susceptibility towards agents generating oxygen reactive species in terms of apoptogenecity and proliferation, and ROS play an important role in the pathogenesis of a variety of renal diseases (13). Moreover, renal cell carcinoma remains one of the most drug-resistant malignancies in humans and is a frequent cause of cancer mortality (14) . 3 Thus, we investigated the relation between the curcumin-induced oxidative response and toxicity in renal carcinoma cells, human renal Caki cells.
Curcumin was also shown to inhibit the in vitro growth of a number of human cancer cell lines (15), the cellular and molecular mechanisms underlying curcumin-induced apoptosis are not yet well defined.
To explore the mechanism of the chemopreventive effects of curcumin, we have tested whether curcumin can induce apoptosis in tumor cells and examined the involvement of these pro-and anti-apoptotic members of the Bcl-2 and IAP family in materializing such apoptogenic effect. We have further analyzed that curcumin activates mitochondria-mediated apoptotic pathway in tumor cells. Curcumin induces cytochrome c release, which activates pro-caspase 3 and DNA fragmentation. Moreover, antioxidant NAC inhibits curcumin-induced apoptosis and prevents the release of cytochrome c from the mitochondria. The data presented here demonstrate that the cytotoxicity of curcumin is due to the induction of apoptosis that is mediated by the direct release of cytochrome c and the subsequent activation of caspases. [OLE1] Human renal carcinoma Caki cells were obtained from the American Type Culture Collection (ATCC: Rockville, MD, USA). The culture medium used throughout these experiments was Dulbecco's modified Eagle's medium, containing 10% fetal calf serum (FCS), 20mM HEPES buffer [OLE2] and 100 µg/ml gentamicin. Curcumin was directly added to cell cultures at the indicated concentrations. Anti-cIAP1, anti-cIAP2, anti-Bcl-4 XIAP from R&D systems (Minneapolis, MN). DEVD-pNA, z-VAD-fmk, and curcumin were purchased from Biomol (Plymouth Meeting, PA, USA).
Materials and methods

Cells and Materials
Western blotting[OLE3]
Cellular lysates were prepared by suspending 1 x 10 6 cells in 100µl of lysis buffer (137 mM NaCl, 15 mM EGTA, 0.1 mM sodium orthovanadate, 15 mM MgCl 2 , 0.1%
Triton X-100, 25 mM MOPS, 100 µM phenylmethylsulfonyl fluoride, and 20 µM leupeptin, adjusted to pH 7.2). The cells were disrupted by sonication and extracted at 4°C for 30 min. The proteins were electrotransferred to Immobilon-P membranes (Millipore Corporation, Bedford, MA, USA). Detection of specific proteins was carried out with an ECL Western blotting kit according to the manufacturer's instructions.
DNA fragmentation Assay
After treatment with curcumin, Caki cells were lysed in a buffer containing 10 mM Tris (pH 7.4), 150 mM NaCl, 5 mM EDTA, and 0.5% triton X-100 for 30 min on ice.
Lysates were vortexed and cleared by centrifugation at 10,000 g for 20 min. Fragmented DNA in the supernatant was extracted with an equal volume of neutral phenol :
chloroform : isoamyl alcohol mixture (25 : 24 : 1) and analyzed electrophoretically on 2% agarose gels containing 0.1 µg/ml of ethidium bromide.
Measurement of Reactive Oxygen Species
The intracellular accumulation of reactive oxygen species (ROS) was determined using the fluorescent probes H 2 DCFDA. H 2 DCFDA was commonly used to measure H 2 O 2 (16), but it is now accepted that this probe is also sensitive to other peroxides (17). With this aim, 1 h prior to treatment with the cytotoxic agents the cells were collected by centrifugation, resuspended in DMEM medium without red phenol, and loaded with either 5 µM H 2 DCFDA. The fluorescence was measured at the desired time intervals by flow cytometry. Control cells were subjected to the same manipulation, except for treatment with the curcumin.
Caspase 3 activity Assay
To evaluate caspase 3 activity, cell lysates were prepared after their respective treatment with curcumin. Assays were performed in 96-well microtitre plates by incubating 20 µg of cell lysates in 100 µl of reaction buffer (1% NP-40, 20 mM TrisHCl, pH 7.5, 137 mM NaCl, 10% glycerol) containing the caspase 3 substrate (DEVDpNA) at 5 µM. Lysates were incubated at 37°C for 2 h. Thereafter, the absorbance at 405 nm was measured with a spectrophotometer.
5 20 mM Tris-HCl, pH7.2, 1mM DTT, 10 mM KCl, 1.5 mM MgCl 2 , 5 µg/ml pepstatin A, 10 µg/ml leupeptin, 2 µg/ml aprotinin). Lysates were centrifuged at 12,000 g at 4°C for 10 min. to obtain the supernatants (cytosolic extracts free of mitochondria) and the pellets (fraction that contains mitochondria). The resulting cytosolic fractions were used as the cytosolic fraction for detecting cytochrome c and the resulting pellets were used as a positive control for mitochondrial protein cytochrome c oxidase (COX) subunit IV.
RNA isolation and Reverse transcriptase-polymerase chain reaction (RT-PCR)
Total RNA was isolated according to published method (18). Single-strand cDNA was synthesized from 2 µg of total RNA using M-MLV reverse transcriptase (Gibco-BRL, Gaithersburg, MD, USA). The cDNA for Akt and actin were amplified by PCR with specific primers. The sequences of the sense and antisense primers for Akt were 5'-CAACTTCTCTGTGGCGCAGTG-3' and 5'-GACAGGTGGAAGAACAGCTCG-3', respectively. Conditions for PCR reaction were 1 X (94°C, 3min); 30 X (94°C, 45 sec; 58°C, 45 sec; and 72°C, 1 min); and 1 X (72°C, 10 min). PCR products were analyzed by agarose gel electrophoresis and visualized by ethidium bromide.
Statistical Significance
All experiments were repeated at least three times with different cells. Values are the mean ± S.D. of these experiments. Significance between experimental values was determined by two-way analysis of variance.
Results
Cytotoxic effect of curcumin on Caki cell death
To verify curcumin-induced cell toxicity, we first examined the changes in cell morphology after curcumin exposure. As shown in figure 1A , exposure to 50 µM curcumin for 24h causes Caki cells to develop characteristic features of cell shrinking, rounding, and partial detachment, thus demonstrating the lobulated appearance of apoptotic cells (Fig. 1A) . We also examined the effects of different concentrations of curcumin on cell viability on Caki cells. Figure 2A , treatment with curcumin results in decreased levels of pro-caspase 3 in Caki cells exposed to 50 to 100 µM curcumin for We also tested the effect of curcumin on induction of apoptosis in leukemia U937 cells, and found that curcumin induces PLC-γ1 cleavage and activation of caspase 3 in U937 cells at even lower concentration than what is required for these effects in Caki cells (Fig. 2C, 2D ).
To address the significance of caspase activation in curcumin-induced apoptosis, we used a general and potent inhibitor of caspases, z-VAD-fmk (benzyloxycarbony-ValAla-Asp-fluoromethyl ketone). Curcumin strongly stimulates caspase 3 protease activities, but 50 µM z-VAD-fmk pretreatment abolishes 75 µM curcumin-induced caspase 3 activities (Fig. 3A) . Furthermore, curcumin treatment of Caki cells generates fmk pretreated cells significantly inhibit cleavage of PLC-γ1 and Bax (Fig. 3B ). These data clearly indicate that curcumin-induced apoptosis is associated with caspase activation.
Modulation of Bcl-2 and IAP protein families in curcumin-induced apoptosis in Caki cells
We also examined whether curcumin induces cell death by modulating the expression of Bcl-2 family members, which ultimately determine the cell's response to apoptotic 
Curcumin induces cytochrome c release in Caki cells
To 
Induction of apoptosis by curcumin appears to be dependent of formation of reactive metabolites.
Many antineoplastic agents eliminate tumor cells by inducing programmed cell death or apoptosis, and numerous investigations have documented the cellular changes resulting from oxidative stress induced in cells following exposure to cytotoxic drugs and UV and γ irradiation (22, 23) . To examine the capacity of curcumin to cause intracellular oxidation, we used a specific fluorescent dye for H 2 O 2 , H 2 DCFDA, which leads to increase fluorescent intensity when cells generated H 2 O 2 . As shown in Fig. 6A , treatment with curcumin increases the H 2 DCFDA-derived fluorescence. This increase in fluorescence is significantly inhibited by anti-oxidant, NAC. To examine the role of reactive oxygen species in curcumin-induced apoptosis, we used the antioxidant, NAC, which has been shown previously thiol antioxidant that has functions as both a redox buffer and a reactive oxygen intermediate scavenger (24) . Caki cells exposed to 10 mM NAC plus 75 µM curcumin for 24h did not exhibit the characteristic features of cell shrinking, rounding, and partial detachment as cells exposed to curcumin alone. As shown in Figure 6B , co-treatment with NAC significantly prevents apoptotic morphological change.
Because prevention of apoptotic morphological change can be mediated in part by inhibition of caspase 3, we next evaluated the effect of NAC on caspase 3 activity. As shown in Figure 7A , caspase 3 activity markedly decreases in cells treated with NAC in addition to 75 µM curcumin. Furthermore, treatment with curcumin significantly decreases levels of pro-caspase 3, but has little effect on cells treated with NCA plus curcumin (Fig. 7B) . We also observed that NAC prevents cleavage of PLC-γ1 in cells treated with NAC plus curcumin (Fig. 7C) . Because cytochrome c release is upstream of caspase 3 activation, we next examined whether NAC has a direct effect on curcuminmediated cytochrome c release. Importantly, as shown in Figure 7D , NAC treatment of Caki cells significantly blocks curcumin-induced release of cytochrome c from the mitochondria into the cytoplasm. These data clearly indicate that NAC prevention of curcumin-induced apoptosis is associated with caspase inactivation and cytochrome c release.
Curcumin induces dephosphorylation of Akt in Caki cells.
Previous studies have demonstrated that Akt activity inhibits the release of cytochrome c from mitochondria after UV irradiation (25) . In addition, constitutively activated Akt significantly protected HMN1 cells from apoptosis induced by C2-ceramide (26) . To determine whether curcumin-induced apoptosis is associated with Akt activity, we determined the expression and phosphorylation levels of Akt in Caki cells after treated with various concentrations of curcumin. As shown in Figure 8A , the levels of phosphorylated Akt are significantly decreased in response to curcumin (75 µM).
Phosphorylation of Akt is associated with activation of this kinase (27, 28) . As shown in Figure 8B , these effects of curcumin are time-dependent; Akt phosphorylation is rapidly decreased within 30 min of treatment, whereas total Akt protein levels remain constant during curcumin treatment.
To determine whether NAC prevents curcumin-mediated dephosphorylation of Akt,
we measured phosphorylation levels of Akt in Caki cells after treatment with curcumin alone, or with NAC. As shown in Figure 8C , NAC treatment significantly blocks curcumin-induced dephosphorylation of Akt and release of cytochrome c from the mitochondria into the cytoplasm in Caki cells. These data clearly indicate that generation of reactive oxygen species is closely associated with curcumin-induced dephosphorylation of Akt, cytochrome c release, and apoptosis. Interestingly, total Akt protein levels are down-regulated by prolonged treatment with curcumin ( Fig. 8A and   8C ).
In further studies of the relationship between total Akt protein and Akt mRNA in Caki cells, we measured Akt mRNA levels by RT-PCT. As shown in Figure 8D , Akt mRNA Recently it has been suggested that oxidative stress plays a role as a common mediator of apoptosis (38) . We report here that curcumin induces oxidative stress and apoptosis in Caki cells, and that the antioxidant NAC prevents apoptosis induced by curcumin. Our data also show that the antioxidant NAC prevents caspase 3 activation, dephosphorylation of Akt and cytochrome c release. Thus, curcumin causes oxidative stress, which then leads to the release of cytochrome c from mitochondria, further initiating the activation of the execution caspases and leading to apoptotic cell death.
Further, the down-regulation of Bcl-2 and IAP family proteins may also lead to the activation of caspase 3. been reported to directly phosphorylate and inactivate procaspase-9 aw well as to block caspase-9-mediated apoptosis induced by cytochrome c via Apaf-1 in response to an early apoptotic stimuli (39) . Akt can also phosphorylate Bad, resulting in the release of Bcl-2 and inhibition of the apoptotic process (30) .
In contrast with our results, it has been reported that curcumin induces caspase-3-independent apoptosis in human multidrug-resistant cells (40) . Moreover, it was demonstrated in Jurkat cells that curcumin induced nontypical apoptosis-like pathway, which was independent of mitochondria and caspase-3 (41). In addition, there are conflicting results regarding its apoptogenic mechanism in other cell types. Piwocka et al. (42) showed that curcumin induced apoptosis through the depletion of glutathione in Jurkat cells, whereas Jaruga et al. (43) reported that curcumin prevent dexamethasoneinduced apoptosis via induction of glutathione synthesis in thymocytes.
Until now, mechanism for curcumin-induced apoptosis is not yet fully defined. Curcumin is worldwidely used as a coloring and flavoring additive in many foods and has attracted interest because of its anti-inflammatory and chemopreventive activities. It has been recently reported that the curcumin required for efficacy of chemopreventivention in humans would be daily dose of 1.6 g per person without adverse effect (44) . It is pharmacokinetically non-permissible to take the human blood volume and calculate concentration of drug on the basis of the dose ingested. Clinical trials of oral curcumin cannot be utilized because of low bioavailability or low target organ concentration due to its rapid metabolism in liver and intestinal wall. However, coingestion of curcumin with the pepper constituent l-piperoylpiperidine, which is though to inhibit xenobiotic glucuronidation, appeared to increased curcumin serum AUC by a factor of 20 (45) . In addition, a recent clinical pilot study in colorectal cancer suggests that Curcuma extract can be administered safely to patients at doses of up to 2.2 g daily, equivalent to 180 mg of curcumin (46) . 
